Scientific Program
| BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 | ||||
| Theme: Rethinking the Next Big Things in Pharma Innovations | ||||
| Time: August 16-19, 2018 Place: Boston Marriott Cambridge, USA |
||||
| Scientific Program | ||||
| Stream 1 | Stream 2 | Stream 3 | Stream 4 | Stream 5 |
| Opening Ceremony and Plenary Forum | |||
|
Day 1: Morning, Thursday, August 16, 2018 Place: Salon III, 2nd Floor |
|||
| Moderator: Dr. Qun (Max) Dang, Vice President & Global Head of BD and External Innovation, PR&D, Qilu Pharmaceutical, China | |||
| Time | FaceOn | Speeches and Speakers | |
| 09:20-09:25 | Moderator's Introduction | ||
| 09:25-09:50 |  |
Title: Iconoclast Therapeutics: Breaking All the Rules of Engagement Dr. Gregory L. Verdine, Founder, CEO & Erving Professor, FogPharma and LifeMine Therapeutics; Harvard University and Harvard Medical School, USA |
|
| 09:50-10:15 |  |
Title: Optimization of a Novel EphA2-antibody Directed Nanotherapeutic for the Treatment of Solid Tumors Dr. Daryl C. Drummond, Senior Vice President and Head of Research, Merrimack Pharmaceuticals, USA |
|
| 10:15-10:40 |  |
Title: Remote Patient Monitoring in Clinical Trials: Ready or Not, Here It Comes Dr. Kenneth G. Faulkner, Corporate Vice President, Patient Technology Solutions, PAREXEL, USA |
|
| 10:40-11:05 |  |
Title: External Collaboration - A Must-have for Future Pharma Innovations Dr. Qun (Max) Dang, Vice President & Global Head of BD and External Innovation, PR&D, Qilu Pharmaceutical, China |
|
| 11:05-11:30 |  |
Title: Building a Brighter/Better Future for Drug Discovery Dr. Tom Mander, Chief Operating Officer, Domainex Ltd., UK |
|
| 12:00-13:00 | Lunch | ||
© 2003-2018 All rights reserved by BITeomics Inc. |